newsfilter
← Latest News
Business Wire·

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

Additional presentations to focus on liquid biopsy– MRD based detection and genomic profiling across solid tumors NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable